Gregory Flesher

Gregory J.
Flesher is President, Chief Executive Officer & Director at Reneo Pharma Ltd. Formerly, Mr. Flesher was Chief Executive Officer & Director at Otic Pharma Ltd. from 2015 to 2017, Chief Executive Officer & Director at Eledon Pharmaceuticals, Inc. from 2017 to 2020, President, Chief Executive Officer & Director at Reneo Pharmaceuticals, Inc., President & Chief Executive Officer at OnKure Therapeutics, Inc., Chief Executive Officer at Ambros Therapeutics, Inc., Director-Hepatology Sales & Pulmonary Marketing at InterMune, Inc. from 2002 to 2006, Director at Adynxx, Inc. from 2019 to 2021, and Chief Business Officer & SVP-Corporate Development at Avanir Pharmaceuticals, Inc. from 2011 to 2015.
Education includes undergraduate studies at Purdue University and The Indiana University School of Medicine.